10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 22, 2023) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents (Note 7) | $ 2,067,000 | 3,818,500 |
| Short-term investments (Note 7) | 144,800 | 90,100 |
| Accounts receivable, net of allowances of $16.0 (2022) and $22.5 (2021) | 6,896,000 | 6,672,800 |
| Other receivables | 1,662,900 | 1,454,400 |
| Inventories (Note 6) | 4,309,700 | 3,886,000 |
| Prepaid expenses and other current assets | 2,954,100 | 2,530,600 |
| Total current assets | 18,034,500 | 18,452,400 |
| Investments (Note 7) | 2,901,800 | 3,212,600 |
| Goodwill (Note 8) | 4,073,000 | 3,892,000 |
| Other intangibles, net (Note 8) | 7,206,600 | 7,691,900 |
| Deferred tax assets (Note 14) | 2,792,900 | 2,489,300 |
| Property and equipment, net (Note 9) | 10,144,000 | 8,985,100 |
| Other noncurrent assets | 4,337,000 | 4,082,700 |
| Total assets | 49,489,800 | 48,806,000 |
| Liabilities and Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt (Note 11) | 1,501,100 | 1,538,300 |
| Accounts payable | 1,930,600 | 1,670,600 |
| Employee compensation | 1,059,800 | 958,100 |
| Sales rebates and discounts | 8,784,100 | 6,845,800 |
| Dividends payable | 1,017,200 | 885,500 |
| Income taxes payable (Note 14) | 475,100 | 126,900 |
| Other current liabilities | 2,370,300 | 3,027,500 |
| Total current liabilities | 17,138,200 | 15,052,700 |
| Other Liabilities | ||
| Long-term debt (Note 11) | 14,737,500 | 15,346,400 |
| Accrued retirement benefits (Note 15) | 1,305,100 | 1,954,100 |
| Long-term income taxes payable (Note 14) | 3,709,600 | 3,920,000 |
| Deferred tax liabilities (Note 14) | 87,300 | 1,733,700 |
| Other noncurrent liabilities | 1,736,700 | 1,644,300 |
| Total other liabilities | 21,576,200 | 24,598,500 |
| Commitments and Contingencies (Note 16) | ||
| Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) | ||
| Common stockno par value Authorized shares: 3,200,000 Issued shares: 950,632 (2022) and 954,116 (2021) | 594,100 | 596,300 |
| Additional paid-in capital | 6,921,400 | 6,833,400 |
| Retained earnings | 10,042,600 | 8,958,500 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss (Note 17) | (3,844,600) | (4,343,100) |
| Cost of common stock in treasury | (50,500) | (52,700) |
| Total Eli Lilly and Company shareholders' equity | 10,649,800 | 8,979,200 |
| Noncontrolling interests | 125,600 | 175,600 |
| Total equity | 10,775,400 | 9,154,800 |
| Total liabilities and equity | 49,489,800 | 48,806,000 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |